Franklin Resources Inc Kodiak Sciences Inc. Transaction History

Franklin Resources Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$3.01 - $7.45 $97,406 - $241,089	32,361 New	32,361 $170,000
Q1 2022 May 13, 2022	SELL	$7.09 - $89.45 $1.32 Million - $16.7 Million	-186,692 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$80.85 - $128.49 $404 - $642	5 Added 0.0%	186,692 $15.8 Million
Q3 2021 Nov 12, 2021	BUY	$81.97 - $106.94 $79,264 - $103,410	967 Added 0.52%	186,687 $17.9 Million
Q2 2021 Aug 13, 2021	BUY	$77.2 - $126.54 $41,070 - $67,319	532 Added 0.29%	185,720 $17.3 Million
Q4 2020 Feb 10, 2021	BUY	$60.78 - $154.03 $11.3 Million - $28.5 Million	185,188 New	185,188 $27.2 Million

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.